Literature DB >> 6377335

Practicable and valid approach to evaluate the efficacy of nootropic drugs by means of rating scales.

E Lehmann.   

Abstract

Starting with the disputable practice of evaluating the efficacy of nootropic drugs the author has developed a strictly experimental examination approach emphasising the internal validity of experiments. The physician's assessment of the global therapeutic effect is suggested as a variable examination factor which should be treated as an independent variable and a valid instrument for judging the effect when arriving at a statistical conclusion. Differentiated rating scales and measurements are suggested as a basis for this judgment. Proven effects are described in a more differentiated manner by means of this method which helps in discussing the validity of results.

Mesh:

Year:  1984        PMID: 6377335     DOI: 10.1055/s-2007-1017411

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  3 in total

1.  Developmental disabilities modification of the Children's Global Assessment Scale.

Authors:  Ann Wagner; Luc Lecavalier; L Eugene Arnold; Michael G Aman; Lawrence Scahill; Kimberly A Stigler; Cynthia R Johnson; Christopher J McDougle; Benedetto Vitiello
Journal:  Biol Psychiatry       Date:  2007-02-15       Impact factor: 13.382

2.  Development and psychometric evaluation of a clinical global impression for schizoaffective disorder scale.

Authors:  Michael H Allen; David G Daniel; Dennis A Revicki; Carla M Canuso; Ibrahim Turkoz; Dong-Jing Fu; Larry Alphs; K Jack Ishak; John J Bartko; Jean-Pierre Lindenmayer
Journal:  Innov Clin Neurosci       Date:  2012-01

3.  Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study.

Authors:  Fletcher B Taylor; Patti Martin; Charles Thompson; Judi Williams; Thomas A Mellman; Christopher Gross; Elaine R Peskind; Murray A Raskind
Journal:  Biol Psychiatry       Date:  2007-09-14       Impact factor: 13.382

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.